Study identifier:3591US/0020
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Multicenter Nonrandomized Trial of Intravenous MERREM (Meropenem, ICI 194,660) for the Treatment of Hospital-Acquired Pneumonia
infectious diseases
Phase 3
-
-
-
-
Interventional
-
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Dec 2013 by AstraZeneca
AstraZeneca
-
No locations available
Arms | Assigned Interventions |
---|